Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$10.97 USD
+0.29 (2.72%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $11.18 +0.21 (1.91%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Sage Therapeutics, Inc. [SAGE]
Reports for Purchase
Showing records 81 - 100 ( 160 total )
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Sage Casts a Spotlight on ?718 and NMDA Program; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Spotlight on SAGE-718 and NMDA Platform (For Today)
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Sage-718 Is Latest Asset to Advance in Rich Pipeline on 1Q Call as We Await WATERFALL
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Final Countdown to WATERFALL - Continue to Like the Chances for Success
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
SAGE-324 Hits Primary Endpoint, But Sage Still Has More Work to Do; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Just The Beginning - SAGE-324 KINETIC Data Signals Advancement
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Notes From The (Virtual) Road... Management Meetings Move Through The LANDSCAPE
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
More Positive Data from SHORELINE Bolsters Confidence in Zuranolone as WATERFALL Readout Nears
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
2021 Poised as a Year of Readouts in Uneventful 4Q Call; Reiterate Buy, PT to $86
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Sage Therapeutics, Inc.
Industry: Medical - Drugs
With WATERFALL Enrollment Complete, Much To Look Forward To In 2021
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L